SIM
OREX

Sterling Investment Management’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Sterling Investment Management’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,503
Closed -$6K – 49
2016
Q2 		$6K Hold
1,503
– – 0.01% 49
2016
Q1 		$8K Hold
1,503
– – 0.01% 49
2015
Q4 		$26K Hold
1,503
– – 0.02% 60
2015
Q3 		$32K Hold
1,503
– – 0.03% 68
2015
Q2 		$74K Hold
1,503
– – 0.06% 66
2015
Q1 		$118K Hold
1,503
– – 0.08% 71
2014
Q4 		$91K Buy
+1,503
New +$75.5K 0.06% 70

Other funds holding OREX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Sterling Investment Management's OREX Position: Q3 2016 in Review

Sterling Investment Management sold out of Orexigen Therapeutics, Inc. (OREX) in Q3 2016, closing a stake of 1,503 shares — an estimated $6K sold.

Sterling Investment Management first reported a position in OREX in Q4 2014 and held it in 7 quarters. The position peaked at $118K in Q1 2015. 55 funds tracked by Wall St. Rank hold OREX as of Q3 2016.

  • Sterling Investment Management reported no remaining Orexigen Therapeutics, Inc. position as of Q3 2016 after selling out during the quarter.
  • Sterling Investment Management sold 1,503 Orexigen Therapeutics, Inc. shares in Q3 2016, an estimated $6K.
  • Sterling Investment Management first reported a position in Orexigen Therapeutics, Inc. in Q4 2014 and held it in 7 quarters.
  • Sterling Investment Management's Orexigen Therapeutics, Inc. position peaked at $118K in Q1 2015.
  • 55 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q3 2016.

Based on Sterling Investment Management's 13F filing for Q3 2016, filed 25 Oct 2016.